Vagus nerve stimulation for refractory posttraumatic epilepsy: Efficacy and predictors of seizure outcome

Guo M, Wang J, Tang C, Deng J, Zhang J, Xiong Z, Liu S, Guan Y, Zhou J, Zhai F, Luan G, Li T

Front Neurol. 2022 Jul 28;13:954509
https://doi.org/10.3389/fneur.2022.954509


The severity of traumatic brain injury (#TBI) is closely related to the relative risk of developing posttraumatic epilepsy (#PTE) [1]. PTE patients are severely drug-resistant, and it is generally difficult to achieve seizure control with brain surgery [2]. 

This new publication by Guo et al. 2022 aimed to examine treatment outcomes of VNS Therapy in patients with drug-resistant PTE.

๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

 - ๐•๐๐’ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ž๐ ๐ข๐ง ๐š๐ง ๐จ๐ฏ๐ž๐ซ๐š๐ฅ๐ฅ ๐ซ๐ž๐ฌ๐ฉ๐จ๐ง๐๐ž๐ซ ๐ซ๐š๐ญ๐ž ๐จ๐Ÿ ๐Ÿ”๐Ÿ’.๐Ÿ’% ๐Ÿ๐จ๐ซ ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐๐“๐„.

- ๐€๐ญ ๐ญ๐ก๐ž ๐ฅ๐š๐ฌ๐ญ ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ-๐ฎ๐ฉ ๐ฌ๐ž๐ฌ๐ฌ๐ข๐จ๐ง, ๐Ÿ๐Ÿ“.๐Ÿ”% ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ก๐š๐ ๐š๐œ๐ก๐ข๐ž๐ฏ๐ž๐ ๐ฌ๐ž๐ข๐ณ๐ฎ๐ซ๐ž ๐Ÿ๐ซ๐ž๐ž๐๐จ๐ฆ.

- ๐๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐Ÿ๐จ๐œ๐š๐ฅ ๐จ๐ซ ๐ฆ๐ฎ๐ฅ๐ญ๐ข๐Ÿ๐จ๐œ๐š๐ฅ ๐ข๐ง๐ญ๐ž๐ซ๐ข๐œ๐ญ๐š๐ฅ ๐ž๐ฉ๐ข๐ฅ๐ž๐ฉ๐ญ๐ข๐Ÿ๐จ๐ซ๐ฆ ๐๐ข๐ฌ๐œ๐ก๐š๐ซ๐ ๐ž๐ฌ (#๐ˆ๐„๐ƒ๐ฌ) ๐ฐ๐ž๐ซ๐ž ๐ฆ๐จ๐ซ๐ž ๐ฅ๐ข๐ค๐ž๐ฅ๐ฒ ๐ญ๐จ ๐›๐ž๐œ๐จ๐ฆ๐ž ๐•๐๐’ ๐ซ๐ž๐ฌ๐ฉ๐จ๐ง๐๐ž๐ซ๐ฌ (โ‰ฅ๐Ÿ“๐ŸŽ% ๐ฌ๐ž๐ข๐ณ๐ฎ๐ซ๐ž ๐Ÿ๐ซ๐ž๐ช๐ฎ๐ž๐ง๐œ๐ฒ ๐ซ๐ž๐๐ฎ๐œ๐ญ๐ข๐จ๐ง).

The medical records of 45 patients (median age at implantation: 22.2 years, IQR: 14.3-33.5 years) with PTE who were treated with VNS Therapy for at least 12 months were retrospectively analyzed in terms of seizure frequency reduction and potential predictive factors of VNS efficiency.

After a median follow-up duration of 3 (IQR: 2.0-4.5) years, a responder rate of 64.4% was observed. 15.6% of the patients were reported to be seizure-free at the last follow-up session. Noteworthy, the responder rate appeared to be time-dependent, increasing from 37.8% at the 3-month follow-up to 44.4%, 60% and 67.6% at the 6-, 12- and 24-month follow up sessions, respectively. Generalized IEDs were associated with worse treatment outcomes.

This study would benefit from the inclusion of treatment outcomes related to the patientsโ€™ quality of life as this is an important factor in the overall efficiency of VNS Therapy. Furthermore, the authors note that they could not include data on TBI #severity due to insufficient information. This is unfortunate but is stated to be included in future studies. Despite the study limitations, the results indicate a beneficial effect of VNS Therapy in patients with drug-resistant PTE, especially for patients without generalized IEDs.

References

1. DOI: http://ow.ly/fQKW50KWSNx

2. DOI: http://ow.ly/mnrJ50KWSNC

 
 
Previous
Previous

Comparison of traditional and closed loop vagus nerve stimulation for treatment of pediatric drug-resistant epilepsy: A propensity-matched retrospective cohort study

Next
Next

VNS parameters for clinical response in epilepsy